FDA Grants Approval for Brivaracetam ANDA219766 by Shandong
The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 219766 for Brivaracetam submitted by Shandong.
Asset / Drug
Drug and asset intelligence for Shandong with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.